
Hypoglycemic drugs are used in the group of metabolic diseases with carbohydrate metabolism disorders, especially diabetes. Different drugs are used depending on the individual characteristics of this disease, the level of compensation and the presence of complications, which allows for individual therapy. Therefore, this article provides detailed information about the use of hypoglycemic drugs and their mechanism of action
metformin; meglitinide; gliptin; derivative sulfonylureas; thiazolidinedione; α-glucosidase inhibitor
metformin; meglitinide; gliptin; derivative sulfonylureas; thiazolidinedione; α-glucosidase inhibitor
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
